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Objective
To evaluate the potential clinical utility of T2 quantita-
tive mapping for myocardial edema in acute disease
pathology - myocarditis, myocardial infarction, Tako-
Tsubo cardiomyopathy, and transplant rejection.
Background
Edema is a generic tissue response to acute myocardial
injury and, therefore; a potential marker of impending
tissue damage. Currently in clinical use, T2 weighted
imaging provides a qualitative technique in assessing
myocardial edema. We hypothesize that quantitative T2
mapping in patients with suspected cases of myocarditis,
myocardial infarction (AMI), and cardiac transplant
rejection will provide a more sensitive and specific diag-
nostic prediction than with T2W imaging, and add to
other imaging techniques.
Method
We used a non-contrast multiplanar single-shot and
cine TrueFISP and steady state free precession (SSFP)
sequence developed by Siemens Healthcare which con-
sists of T2-prepared, linear flip angle series of 20, 60,
and 90 degrees, and SSFP readout. ECG triggered
breathold T2 mapping was done on the three short axis
and 4 chamber images on a 1.5 T scanner (MAGNE-
TOM Avanto, Siemens Erlangen, Germany). Regions of
interest (ROI) based on the 17 segment myocardial
model were drawn by two blinded reviewers (AU and
MW) for inter-rater and intra-rater reliability.
Results
Complete results are presented in table 1. T2 mapping
was done on 6 suspected acute myocarditis, 13 AMI, 1
Tako-Tsubo cardiomyopathy, and 25 transplant patients.
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Table 1 Demographics
Total cases 65
Group Controls Transplant AMI Myocarditis Cardiomyopathy
Average age 32.7 ± 7.3 55.8 ± 13.8 55.5 ± 10.3 49.2 ± 13.2 60
Percent female 50% 44% 33% 33% 100%
Normal** 20 22 4 3 0
Disease NA 3 8 3 1
Total 20 25 12 6 1
Outcomes
Average T2 Normal ROI (ms) 51.2 ± 2.7 52.1 ± 2.4 54.1 ± 3.1 54.0 ± 3.7 52.3 ± 3.1
Average T2 Disease ROI (ms) NA 61.6 ± 3.1 65.0 ± 4.4 67.1 ± 7.5 68.0 ± 4.2
Significance NA <0.05 <0.05 <0.05 <0.05*
Ejection fraction 62% 58.7% 39.$% 41/1% 32.2%
*p-value compared internally from basal segment to mid and apical segment.
** Normal represents cases that were suspected to have outcome, i.e. AMI, myocarditis, etc, but were by clinical assessment MRI, and cellular pathology
determined not to have any disease. These cases T2 Mapping were compared to cases with in-group pathology.
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The average age of all patients was 50.9 ± 7.8 years old,
62% male, and average scan time was 45 minutes. Con-
trol studies on normal patients demonstrated a global
T2 mapping average of 51.2 ± 2.7 ms. Of the 6 patients
with suspected myocarditis 3 were found to have no
myocarditis based on MR criteria and clinical follow-up
(100% concordance with T2 mapping). The 3 patients
with myocarditis had cardiac sarcoidosis, viral, and giant
cell myocarditis with average T2 of 70.6 ± 6.7 ms
(p<0.05). 10/12 suspected AMI patients had segmentally
concordant T2 values in relation to delayed enhance-
ment outcomes. The average infract segment T2 value
was 66.4 ± 3.2 ms (p<0.05). The basal T2 value in the
Tako-Tsubo case was 52.3 ± 3.2 ms, while the mid and
apical average were 68.0 ± 4.2 ms (p<0.05). Figure 1
Conclusions
T2 quantification provides a useful clinical tool in evalu-
ating cardiac pathology with acute cellular responses
and edema. We hope with advances in spatial and tem-
poral resolution T2 mapping can be used to determine
myocardial viability in cases of AMI, predict transplant
rejection, or help rule-out myocarditis.
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